Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or West Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to West Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. West Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Rajiv Khanna (NPI 1518955913)

Field	Value
Entity Type	Individual
Organization	Rajiv Khanna
Address	275 Dry Hill Rd
City	Beckley
State	WV
ZIP	25801
Taxonomy	Medical Oncology Physician
NPI Enumerated	October 10, 2005

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

Key Findings

This provider’s billing is effectively single‑payer: lifetime Medicare revenue is $2M and there is no Medicaid billing on file. The absence of any Medicaid claims means the practice’s payer mix is concentrated almost entirely with Medicare, which has implications for reimbursement exposure and contract negotiating leverage.

Revenue is highly concentrated in a very small number of drug administration codes: the precomputed top three Medicare codes account for 77.7% of this provider’s total Medicare revenue, with J9271 alone accounting for $1M (55.3% of Medicare revenue). That concentration indicates the practice’s financial performance is heavily dependent on a few high-cost injectable oncology agents.

The code mix and descriptions identify an infusion‑based oncology operation: large volumes for J9271 (pembrolizumab) and J9299 (nivolumab) together with chemotherapy administration codes such as 96413 and add‑ons like 96411 point to routine systemic therapy delivery. Supportive and biologic agents recorded—Q5108 (pegfilgrastim‑jmdb), Q5119 (rituximab‑pvvr), and J0897 (denosumab)—underscore a practice model centered on in‑office infused and injected oncology therapeutics rather than procedure‑oriented subspecialties.

Competitive standing for the top revenue drivers is mixed. J9271 ranks #242 of 1841 providers nationally (87th percentile) and is noted in the dataset as a "typical, unremarkable volume" for that code despite its large share of this provider’s revenue; J9299 ranks #202 of 505 (60th percentile, "typical, unremarkable volume"); by contrast, 96413 ranks #301 of 7514 (96th percentile) and is labeled "notably above typical national volume," indicating relatively high chemo administration throughput compared with peers.

Several individual codes are flagged as statistical outliers on utilization, signaling operational intensity in certain workflows. 96523 (irrigation of venous access) ranks in the 99th percentile and is described as an "extreme outlier," 96411 (chemo add‑on) ranks in the 97th percentile as "notably above typical," and 96372 (therapeutic injection) is in the 99th percentile and also described as "notably above typical," together suggesting frequent use of vascular access and repeated injection/infusion events.

Procedural and ancillary volumes support a high-throughput infusion practice rather than a primarily clinic‑visit model: 36415 (venipuncture) shows 1.6K claims and ranks in the 98th percentile, and office E/M codes such as 99213 and 99214 are present but contribute modestly to revenue. This mix implies operational focus on drug administration and in‑office procedures with relatively fewer revenue dollars from standard office visits.

From a payer management perspective, the largest cost drivers to target would be high-revenue injectable drugs: J9271 ($1M) and J9299 ($361.7K). Given the lack of Medicaid billing, utilization management and cost-containment efforts for this provider should be oriented toward Medicare payment policies and oncology drug management strategies, including site‑of‑care and biosimilar substitution where appropriate.

The provider is an established clinician by tenure: NPI enumerated 2005-10-10 (~21 years ago), which suggests a long‑standing presence in the market and likely stable referral and operational patterns. That longevity, combined with the specialized infusion profile, indicates predictable utilization patterns that payers can model for contracting and utilization review purposes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

84 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	24,230	$40	$1M
J9299	Injection, nivolumab, 1 mg	17,220	$20	$361.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	670	$90	$60.8K
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	620	$90	$58K
J0897	Injection, denosumab, 1 mg	3,000	$20	$51K
74177	The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs.	250	$160	$39K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	1,620	$20	$38.9K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	18,300	$1	$36.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	490	$70	$32.6K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	310	$90	$26.8K

Showing 1–10 of 84

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 84 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. West Virginia Distribution

Rajiv Khanna — 12 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — West Virginia

Full comparison — all codes billed, vs. state median

84 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	1	10	21,430	$40	$920.6K
J9299	1	10	17,220	$20	$365.4K
Q5108	1	10	580	$90	$52.3K
J0897	6	20	2,160	$20	$50.3K
Q5119	1	10	1,620	$20	$38.9K
J0881	1	10	16,220	$1	$37.2K
J2506	1	10	310	$90	$26.7K
96413	1	10	170	$90	$19.5K
J9217	2	10	100	$130	$15.9K
Q0138	1	10	34,680	$1	$13.4K

Showing 1–10 of 84

Related Providers

Other providers that share a Tax Identification Number (TIN) with Rajiv Khanna, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Charleston Area Medical Center Inc	WV	General Acute Care Hospital	$0	$200.1M
Charleston Area Medical Center, Inc.	WV	General Acute Care Hospital	$0	$50.9M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Somc Medical Care Foundation, Inc.	OH	Family Medicine Physician	$0	$25.3M
Rainelle Medical Center Inc	WV	Federally Qualified Health Center (FQHC)	$0	$14.3M
Mark Le	FL	Diagnostic Radiology Physician	$10.7M	$0
Beckley Oncology Associates Inc	WV	Radiation Oncology Clinic/Center	$0	$5M
Charleston Area Medical Center, Inc.	WV	Hospitalist Physician	$0	$1.4M
Mayez El-harake	WV	Medical Oncology Physician	$1.1M	$0
Linda Armstrong	GA	Diagnostic Radiology Physician	$643.9K	$175.1K

Nearby Providers

Other providers in the same ZIP code as Rajiv Khanna, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Raleigh General Hospital LLC	WV	General Acute Care Hospital	$0	$36.4M
Community Health Systems, Inc.	WV	Federally Qualified Health Center (FQHC)	$0	$35M
Fmrs Health Systems Inc	WV	Community/Behavioral Health Agency	$0	$27M
Health Care Alliance, Inc.	WV	Emergency Medicine Physician	$0	$25M
Jan-care Ambulance Of Raleigh County Inc	WV	Land Ambulance	$1.9M	$20.8M
Appalachian Regional Healthcare, Inc	WV	General Acute Care Hospital	$0	$18.3M
Raleigh County Commission On Aging, Inc.	WV	Home Health Agency	$0	$16.7M
Mountain State Home Health Care Inc	WV	Nursing Care Agency	$0	$16.5M
Family Options Providers, LLC.	WV	Community/Behavioral Health Agency	$0	$16.1M
Raleigh County Commission On Aging, Inc.	WV	Home Health Agency	$0	$13.8M

Rajiv Khanna — Billing Profile & Reimbursement Data

Sign up for Rajiv Khanna — Billing Profile & Reimbursement Data policy alerts

Rajiv Khanna — Billing Profile & Reimbursement Data

Sign up for Rajiv Khanna — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References